Filing Details
- Accession Number:
- 0001585364-15-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-24 16:26:47
- Reporting Period:
- 2015-02-20
- Filing Date:
- 2015-02-24
- Accepted Time:
- 2015-02-24 16:26:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1585364 | Perrigo Co Plc | PRGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1398276 | Thomas Farrington | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Senior Vp And Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2015-02-20 | 517 | $151.18 | 321 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 2,098 | Indirect | By 401(k) Plan |
Footnotes
- This transaction was effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on 12/1/2014. This 10b5-1 sales plan will expire on the close of business 12/1/2015.
- Price is a weighted average. Actual priced received ranged from $151.06 - $151.29. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each seperate price within the range.